Xaira Therapeutics, which aims to use AI models to find new drugs to treat diseases, emerged from stealth with $1B in commitments from Sequoia and others — - Marc Tessier-Lavigne resigned from Stanford after controversy — New startup has backing from high-wattage tech investors
Posted from: this blog via Microsoft Power Automate.